fluoxetine has been researched along with Endocrine System Diseases in 1 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Endocrine System Diseases: Pathological processes of the ENDOCRINE GLANDS, and diseases resulting from abnormal level of available HORMONES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camp, MC | 1 |
| Macpherson, KP | 1 |
| Lederle, L | 1 |
| Graybeal, C | 1 |
| Gaburro, S | 1 |
| Debrouse, LM | 1 |
| Ihne, JL | 1 |
| Bravo, JA | 1 |
| O'Connor, RM | 1 |
| Ciocchi, S | 1 |
| Wellman, CL | 1 |
| Lüthi, A | 1 |
| Cryan, JF | 1 |
| Singewald, N | 1 |
| Holmes, A | 1 |
1 other study available for fluoxetine and Endocrine System Diseases
| Article | Year |
|---|---|
Genetic strain differences in learned fear inhibition associated with variation in neuroendocrine, autonomic, and amygdala dendritic phenotypes.
Topics: Amygdala; Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Anxiety Disorders | 2012 |